Electroconvulsive therapy and muscle relaxants

Affiliations

¹ Department of Anesthesiology and Pain Medicine, Daejeon Eulgi University Hospital, School of Medicine, University of Eulji, Daejeon, Korea.
² Department of Anesthesiology and Pain Medicine, Asan Medical Center, School of Medicine, University of Ulsan, Seoul, Korea.

Hong Seuk Yang et al. Anesth Pain Med (Seoul). 2023 Oct.

. 2023 Oct;18(4):447-448.

doi: 10.17085/apm.23018. Epub 2023 Jul 14.

¹ Department of Anesthesiology and Pain Medicine, Daejeon Eulgi University Hospital, School of Medicine, University of Eulji, Daejeon, Korea.
² Department of Anesthesiology and Pain Medicine, Asan Medical Center, School of Medicine, University of Ulsan, Seoul, Korea.

No abstract available

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

1. Kaur M, Chhabra S, Bhatia P, Chouhan RS. Electroconvulsive therapy in a catatonia patient: succinylcholine or no succinylcholine? Anesth Pain Med (Seoul) 2022;17:454–5. - PMC - PubMed
1. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3–16. - PubMed
1. Joung KW, Park DH, Jeong CY, Yang HS. Anesthetic care for electroconvulsive therapy. Anesth Pain Med (Seoul) 2022;17:145–56. - PMC - PubMed
1. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. effects on neuromuscular blockers. Anesthesiology. 1992;76:822–43. - PubMed
1. Saricicek V, Sahin L, Bulbul F, Ucar S, Sahin M. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression? J ECT. 2014;30:30–4. - PubMed